$ 194.09
Updated 09:04:18
Change % 0.00% Stock price unchanged
Change 0.00 Stock price unchanged
Volume 1,865,658
High $ 194.77
Low $ 188.19
Open $ 193.03
ISIN
Prev close $ 191.44
# of shares 637.22M
Market cap 123,678M USD
Intraday

Market closed
Amgen Inc
Market is closed, opens at 14:30
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  194.09 -1.9% Stock price decreasing 0.5% Stock price increasing -2.7% Stock price decreasing 5.1% Stock price increasing 9.8% Stock price increasing
Powered by TradingView

News about Amgen Inc

  • English
  • Regulatory news

Related

Latest 1 week 1 month 3 months 6 months 1 year
YTD
 
Competitors Open
 
Abbott Laboratories 70.92 -0.8% Stock price decreasing -2.6% Stock price decreasing 6.5% Stock price increasing 12.3% Stock price increasing 29.1% Stock price increasing 24.3% Stock price increasing
 
Bristol-Myers Squibb Company 52.58 1.1% Stock price increasing -1.5% Stock price decreasing -13.1% Stock price decreasing -1.0% Stock price decreasing -16.6% Stock price decreasing -14.2% Stock price decreasing
 
Johnson & Johnson 145.26 -0.5% Stock price decreasing -0.1% Stock price decreasing 4.9% Stock price increasing 18.4% Stock price increasing 2.9% Stock price increasing 4.0% Stock price increasing
 
Eli Lilly and Company 114.09 -2.1% Stock price decreasing 1.7% Stock price increasing 8.0% Stock price increasing 32.9% Stock price increasing 31.6% Stock price increasing 35.1% Stock price increasing
 
Merck & Company Inc (new) 77.42 -1.0% Stock price decreasing 3.4% Stock price increasing 12.1% Stock price increasing 24.2% Stock price increasing 37.4% Stock price increasing 37.6% Stock price increasing
 
Pfizer Inc 44.40 -1.6% Stock price decreasing 0.3% Stock price increasing 4.9% Stock price increasing 22.3% Stock price increasing 22.6% Stock price increasing 22.6% Stock price increasing
 
Merck Kgaa O.N. 95.98 -3.0% Stock price decreasing 1.2% Stock price increasing 7.7% Stock price increasing 14.3% Stock price increasing 6.8% Stock price increasing 6.9% Stock price increasing
 
Novartis NAM SF 0,50 76.58 -5.6% Stock price decreasing -2.5% Stock price decreasing 5.9% Stock price increasing 19.2% Stock price increasing 7.8% Stock price increasing 8.4% Stock price increasing
 
Roche Hldg AG GEN 222.80 -2.9% Stock price decreasing 2.6% Stock price increasing 6.8% Stock price increasing 24.1% Stock price increasing 8.9% Stock price increasing 5.8% Stock price increasing
 
Glaxosmithkline PLC ORD 25P 1,489.40 -1.4% Stock price decreasing -5.2% Stock price decreasing -0.3% Stock price decreasing -3.0% Stock price decreasing 14.3% Stock price increasing 12.6% Stock price increasing
 
Takeda PHARM.CO.LTD. 28.38 -12.4% Stock price decreasing -17.6% Stock price decreasing -19.0% Stock price decreasing -15.3% Stock price decreasing -39.3% Stock price decreasing -39.4% Stock price decreasing
 
Sanofi 78.45 -0.8% Stock price decreasing -2.2% Stock price decreasing 7.1% Stock price increasing 17.4% Stock price increasing 6.6% Stock price increasing 9.2% Stock price increasing
 
Biogen Inc 319.44 -1.0% Stock price decreasing -1.8% Stock price decreasing -5.4% Stock price decreasing 4.2% Stock price increasing -2.6% Stock price decreasing 0.3% Stock price increasing
 
Bayer AG NA O.N. 62.19 -4.8% Stock price decreasing -12.4% Stock price decreasing -11.6% Stock price decreasing -36.1% Stock price decreasing -40.9% Stock price decreasing -40.2% Stock price decreasing
 
Teva Pharmaceutical Industries.. 18.44 -10.3% Stock price decreasing -21.4% Stock price decreasing -15.7% Stock price decreasing -20.5% Stock price decreasing 12.2% Stock price increasing -2.7% Stock price decreasing

Company profile

Amgen Inc is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix and received approval for bone-strengthening drug Prolia/Xgeva.

Peers

Instruments Last Change  
Abbott Labor.. 70.92 1.4% Stock price increasing
Bristol-Myer.. 52.58 -0.9% Stock price decreasing
Johnson & Jo.. 145.26 -0.1% Stock price decreasing
Eli Lilly an.. 114.09 0.4% Stock price increasing
Merck & Comp.. 77.42 0.9% Stock price increasing
Pfizer Inc 44.40 1.1% Stock price increasing
Merck Kgaa O.. 95.98 0.4% Stock price increasing
Novartis NAM.. 76.58 1.3% Stock price increasing
Roche Hldg A.. 222.80 2.2% Stock price increasing
Glaxosmithkl.. 1,489.40 1.3% Stock price increasing
Takeda PHARM.. 28.38 -3.0% Stock price decreasing
0,0,0,0,0,0,0,0,0,0
Sanofi 78.45 2.0% Stock price increasing
Biogen Inc 319.44 0.0% Stock price unchanged
Bayer AG NA .. 62.19 2.3% Stock price increasing
Teva Pharmac.. 18.44 -5.0% Stock price decreasing

Copyright Berlingske Media 2018  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
11 December 2018 09:57:31
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20181207.1 - EUROWEB3 - 2018-12-11 10:57:31 - 2018-12-11 09:57:31 - 1000 - Website: OKAY